Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mallepalli, Jyothi
RA-BRANCH, NCT04086745: A Study of Baricitinib in Participants With Rheumatoid Arthritis	Recruiting	4	1300	US	Baricitinib, LY3009104, TNF Inhibitor, Etanercept, Adalimumab	Eli Lilly and Company, Incyte Corporation	Rheumatoid Arthritis	12/24	02/26
NCT05758415: Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy	Active, not recruiting	3	61	Europe, US, RoW	Secukinumab, AIN457, Placebo	Novartis Pharmaceuticals	Rotator Cuff Tendinopathy	10/24	12/24